Atrial stunning as a risk factor for thromboembolic events after cardioversion of atrial flutter

Leonie Hahn; Alvaro Petersen-Uribe; Thomas Nordt; Elke Roser

PMC · DOI:10.1093/ehjcr/ytag127·February 26, 2026

Atrial stunning as a risk factor for thromboembolic events after cardioversion of atrial flutter

Leonie Hahn, Alvaro Petersen-Uribe, Thomas Nordt, Elke Roser

PDF

Open Access

Abstract

Linked entities

Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.

Species1

Homo sapiens(human · species)

Chemicals3

Apixaban DOAC heparin

Diseases8

Atrial stunning subdural haematoma fatigue thrombotic atrial flutter atrial fibrillation thromboembolic LAA

Figures1

Click any figure to enlarge with its caption.

Peer Reviews

No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.

Videos

No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.

Taxonomy

TopicsAtrial Fibrillation Management and Outcomes · Cardiac Arrhythmias and Treatments · Cardiac pacing and defibrillation studies